Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Not Applicable
    1
    50%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution1 total trials
    N/ANon-phased studies
    1(100.0%)

    Highest Phase Reached

    Unknown

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Completed(2)

    Detailed Status

    Completed2

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    N/A

    Trials by Phase

    N/A1 (100.0%)

    Trials by Status

    completed2100%

    Recent Activity

    0 active trials
    Showing 2 of 2
    completednot_applicable

    Reproductive Outcomes of Different Sperm Selection Techniques for ICSI Patients With Abnormal Sperm DNA Fragmentation.

    NCT04482517
    completed

    Effect of Sperm Selection Techniques on Human Neonatal Gender Ratio in Patients Undergoing ICSI

    NCT03922568

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT04482517Not Applicable

    Reproductive Outcomes of Different Sperm Selection Techniques for ICSI Patients With Abnormal Sperm DNA Fragmentation.

    Completed
    NCT03922568

    Effect of Sperm Selection Techniques on Human Neonatal Gender Ratio in Patients Undergoing ICSI

    Completed

    All 2 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    2